Healios K.K. (OTCMKTS:HLOSF – Get Free Report)’s stock price traded up 8.8% on Friday . The stock traded as high as $2.10 and last traded at $2.10. 200 shares changed hands during trading, a decline of 88% from the average session volume of 1,714 shares. The stock had previously closed at $1.93.
Healios K.K. Stock Up 8.8%
The stock’s fifty day moving average price is $2.59 and its 200 day moving average price is $3.34.
Healios K.K. Company Profile
Healios K.K. is a Tokyo–based biotechnology company focused on the development and commercialization of regenerative medicine products and services. The company’s core expertise lies in induced pluripotent stem cell (iPSC)–derived therapies, with a pipeline that includes retinal pigment epithelium (RPE) cells for age‐related macular degeneration and neural cell products targeting neurological disorders. Healios operates a specialized cell processing center in Chuo‐ku, Tokyo, adhering to stringent quality standards for clinical‐grade cell manufacturing.
Beyond its proprietary programs, Healios provides contract development and manufacturing services (CDMO) to pharmaceutical and research institutions.
Featured Stories
- Five stocks we like better than Healios K.K.
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- Wall Street Alert: Buy AES
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.
